ALAB - Company ID 0001736297
The table below shows Astera Labs, Inc.'s balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash & equivalents | $167.61M | $79.55M |
| Short-term investments | - | - |
| Receivables | $83.20M | $38.81M |
| Inventory | $58.98M | $43.22M |
| Total current assets | $1.36B | $1.01B |
| Property, plant & equipment | $92.04M | $35.65M |
| Goodwill | - | - |
| Total assets | $1.53B | $1.05B |
| Accounts payable | $42.36M | $26.92M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $133.04M |
| $86.54M |
| Long-term debt | - | - |
| Total liabilities | $168.19M | $89.71M |
| Retained earnings | $10.34M | -$208.80M |
| Total equity | $1.36B | $964.80M |